Pharmacokinetics of gatifloxacin mesylate tablets in healthy volunteers
Wei Li
Abstract
Wei Li
Abstract
AIM: To study the pharmocokinetics characteristics of gatifloxacin mesylate tablets in healthy volunteers in order to providing the verification of clinical safety and reasonable application of them. METHODS: Eighteen male subjects received a single oral dose of 400 mg of gatifloxacin mesylate. The plasma concentration of gatifloxacin mesylate was determined by HPLC method. RESULTS: The main pharmacokinetics parameters of gatifloxacin mesylate were as follows: T_ max, C_ max, T__ 12β, AUC_ (0-24) were (1.5±s 0.4) h, (3.4±1.0) mg·L -1,(6.6±1.0) h, (33±10) mg·h·L -1, respectively. CONCLUSION: The pharmacokinetics of gatifloxacin mesylate tablets are similar to those of gatifloxacin hydrochloride. It has advantage of quick absorption, high bioavailability and long mean retention time and inter-individual variability.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To study the pharmocokinetics characteristics of gatifloxacin mesylate tablets in healthy volunteers in order to providing the verification of clinical safety and reasonable application of them. METHODS: Eighteen male subjects received a single oral dose of 400 mg of gatifloxacin mesylate. The plasma concentration of gatifloxacin mesylate was determined by HPLC method. RESULTS: The main pharmacokinetics parameters of gatifloxacin mesylate were as follows: T_ max, C_ max, T__ 12β, AUC_ (0-24) were (1.5±s 0.4) h, (3.4±1.0) mg·L -1,(6.6±1.0) h, (33±10) mg·h·L -1, respectively. CONCLUSION: The pharmacokinetics of gatifloxacin mesylate tablets are similar to those of gatifloxacin hydrochloride. It has advantage of quick absorption, high bioavailability and long mean retention time and inter-individual variability.
Key concepts: Gatifloxacin, Mesylate, Bioavailability, Pharmacokinetics, Pharmacology, Medicine, Chemistry, Chromatography